Selecting the appropriate hurdles and endpoints for pentilludin, a novel antiaddiction pharmacotherapeutic targeting the receptor type protein tyrosine phosphatase D.
Description
Frontiers in Psychiatry; 05/01/2023(AN 163478598); ISSN: 16640640Complementary Index